GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinovac Biotech Ltd (FRA:SVQ) » Definitions » Pretax Margin %

Sinovac Biotech (FRA:SVQ) Pretax Margin % : -29.05% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Sinovac Biotech Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sinovac Biotech's Pre-Tax Income for the six months ended in Dec. 2023 was €-82.0 Mil. Sinovac Biotech's Revenue for the six months ended in Dec. 2023 was €282.3 Mil. Therefore, Sinovac Biotech's pretax margin for the quarter that ended in Dec. 2023 was -29.05%.

The historical rank and industry rank for Sinovac Biotech's Pretax Margin % or its related term are showing as below:

FRA:SVQ' s Pretax Margin % Range Over the Past 10 Years
Min: -34.14   Med: 12.19   Max: 90.65
Current: -34.14


FRA:SVQ's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -155.495 vs FRA:SVQ: -34.14

Sinovac Biotech Pretax Margin % Historical Data

The historical data trend for Sinovac Biotech's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinovac Biotech Pretax Margin % Chart

Sinovac Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.78 42.42 90.65 1.69 -34.14

Sinovac Biotech Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.17 76.42 -321.31 -45.30 -29.05

Competitive Comparison of Sinovac Biotech's Pretax Margin %

For the Biotechnology subindustry, Sinovac Biotech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinovac Biotech's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Sinovac Biotech's Pretax Margin % falls into.



Sinovac Biotech Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Sinovac Biotech's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-140.332/411.063
=-34.14 %

Sinovac Biotech's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-82.002/282.312
=-29.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinovac Biotech  (FRA:SVQ) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Sinovac Biotech Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Sinovac Biotech's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinovac Biotech (FRA:SVQ) Business Description

Traded in Other Exchanges
N/A
Address
No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085
Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.

Sinovac Biotech (FRA:SVQ) Headlines

No Headlines